• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

呼吁行动:预防住院患者静脉血栓栓塞症——美国心脏协会政策声明

Call to Action to Prevent Venous Thromboembolism in Hospitalized Patients: A Policy Statement From the American Heart Association.

出版信息

Circulation. 2020 Jun 16;141(24):e914-e931. doi: 10.1161/CIR.0000000000000769. Epub 2020 May 7.

DOI:10.1161/CIR.0000000000000769
PMID:32375490
Abstract

Venous thromboembolism (VTE) is a major preventable disease that affects hospitalized inpatients. Risk stratification and prophylactic measures have good evidence supporting their use, but multiple reasons exist that prevent full adoption, compliance, and efficacy that may underlie the persistence of VTE over the past several decades. This policy statement provides a focused review of VTE, risk scoring systems, prophylaxis, and tracking methods. From this summary, 5 major areas of policy guidance are presented that the American Heart Association believes will lead to better implementation, tracking, and prevention of VTE events. They include performing VTE risk assessment and reporting the level of VTE risk in all hospitalized patients, integrating preventable VTE as a benchmark for hospital comparison and pay-for-performance programs, supporting appropriations to improve public awareness of VTE, tracking VTE nationwide with the use of standardized definitions, and developing a centralized data steward for data tracking on VTE risk assessment, prophylaxis, and rates.

摘要

静脉血栓栓塞症(VTE)是一种严重的可预防疾病,影响住院患者。风险分层和预防措施有充分的证据支持其使用,但存在多种原因导致其不能完全采用、遵守和有效,这可能是过去几十年 VTE 持续存在的原因。本政策声明对 VTE、风险评分系统、预防和跟踪方法进行了重点回顾。根据这份总结,美国心脏协会提出了 5 个主要的政策指导领域,相信这将有助于更好地实施、跟踪和预防 VTE 事件。它们包括对所有住院患者进行 VTE 风险评估并报告 VTE 风险水平,将可预防的 VTE 作为医院比较和绩效付费计划的基准,支持拨款以提高公众对 VTE 的认识,使用标准化定义在全国范围内跟踪 VTE,以及为 VTE 风险评估、预防和发生率的数据跟踪建立集中的数据管理员。

相似文献

1
Call to Action to Prevent Venous Thromboembolism in Hospitalized Patients: A Policy Statement From the American Heart Association.呼吁行动:预防住院患者静脉血栓栓塞症——美国心脏协会政策声明
Circulation. 2020 Jun 16;141(24):e914-e931. doi: 10.1161/CIR.0000000000000769. Epub 2020 May 7.
2
Overuse of venous thromboembolism prophylaxis among hospitalized patients with liver disease.住院肝病患者静脉血栓栓塞症预防过度。
Eur J Haematol. 2020 Mar;104(3):223-229. doi: 10.1111/ejh.13363. Epub 2020 Jan 19.
3
A review of venous thromboembolism prophylaxis for hospitalized medical patients.住院内科患者静脉血栓栓塞症预防措施的综述
Hosp Pract (1995). 2013 Aug;41(3):60-9. doi: 10.3810/hp.2013.08.1069.
4
Development of national performance measures on the prevention and treatment of venous thromboembolism.制定国家静脉血栓栓塞症预防与治疗绩效指标。
J Thromb Thrombolysis. 2010 Feb;29(2):148-54. doi: 10.1007/s11239-009-0407-2.
5
Risk and prophylaxis of venous thromboembolism in hospitalized psychiatric patients. A review.住院精神科患者静脉血栓栓塞的风险与预防:一项综述
Psychiatr Pol. 2018 Jun 30;52(3):421-435. doi: 10.12740/PP/78891.
6
VTE Risk Profiles and Prophylaxis in Medical and Surgical Inpatients: The Identification of Chinese Hospitalized Patients' Risk Profile for Venous Thromboembolism (DissolVE-2)-A Cross-sectional Study.内科和外科住院患者的 VTE 风险特征和预防:中国住院患者静脉血栓栓塞症风险特征的识别(DissolVE-2)-一项横断面研究。
Chest. 2019 Jan;155(1):114-122. doi: 10.1016/j.chest.2018.09.020. Epub 2018 Oct 6.
7
Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.内科疾病患者的静脉血栓栓塞症延伸预防:NATF 抗凝行动倡议。
Am J Med. 2020 May;133 Suppl 1:1-27. doi: 10.1016/j.amjmed.2019.12.001.
8
Results of a venous thromboembolism prophylaxis program for hospitalized patients.一项针对住院患者的静脉血栓栓塞预防计划的结果
Vasc Health Risk Manag. 2016 Dec 12;12:491-496. doi: 10.2147/VHRM.S101880. eCollection 2016.
9
Venous thromboembolism risk and prophylaxis in hospitalised medically ill patients. The ENDORSE Global Survey.静脉血栓栓塞风险与住院内科患者的预防。ENDORSE 全球调查。
Thromb Haemost. 2010 Apr;103(4):736-48. doi: 10.1160/TH09-09-0667. Epub 2010 Feb 2.
10
Venous thromboembolism risk stratification in medically-ill hospitalized cancer patients. A comprehensive cancer center experience.内科住院癌症患者静脉血栓栓塞风险分层。综合癌症中心的经验。
J Thromb Thrombolysis. 2010 Oct;30(3):286-93. doi: 10.1007/s11239-010-0445-9.

引用本文的文献

1
R .R.
Res Pract Thromb Haemost. 2025 Jul 18;9(5):102973. doi: 10.1016/j.rpth.2025.102973. eCollection 2025 Jul.
2
STAMP: surgical thromboprophylaxis adherence management programme.STAMP:外科血栓预防依从性管理计划。
BMJ Open Qual. 2025 Jul 30;14(3):e003063. doi: 10.1136/bmjoq-2024-003063.
3
Suspected Hematuria: Adverse Effects of Rivaroxaban in Older Adult Treated for Atrial Fibrillation.疑似血尿:利伐沙班在老年房颤患者治疗中的不良反应
Reports (MDPI). 2024 Feb 8;7(1):11. doi: 10.3390/reports7010011.
4
Smart Technology Facilitated Patient-Centered Venous Thromboembolism Management (the SmaVTE Study): Protocol for a Randomized Controlled Trial.智能技术辅助的以患者为中心的静脉血栓栓塞管理(SmaVTE研究):一项随机对照试验的方案
JMIR Res Protoc. 2025 Jun 5;14:e67254. doi: 10.2196/67254.
5
Nurses' knowledge, attitudes, and practices regarding deep vein thrombosis and the nursing management.护士关于深静脉血栓形成及护理管理的知识、态度和实践。
Sci Rep. 2025 May 17;15(1):17174. doi: 10.1038/s41598-025-96551-0.
6
Decrease Venous Thromboembolism Without Anticoagulation in Plastic Surgery: The Paradigm of Risk Identification, Risk Modification, and Risk Reduction.整形外科中无需抗凝即可降低静脉血栓栓塞:风险识别、风险修正和风险降低的范例
Plast Surg (Oakv). 2025 May;33(2):208-217. doi: 10.1177/22925503231210876. Epub 2023 Nov 9.
7
A Call to Action for Anticoagulation Stewardship to Address Suboptimal Thromboprophylaxis Practices for at-Risk Non-Orthopedic Surgical Patients in Vietnam: An Explanatory Sequential Mixed-Methods Study.呼吁开展抗凝管理行动,以解决越南高危非骨科手术患者血栓预防措施欠佳的问题:一项解释性序列混合方法研究
Vasc Health Risk Manag. 2025 Apr 24;21:305-326. doi: 10.2147/VHRM.S505100. eCollection 2025.
8
Oral anticoagulant use among Medicare patients newly diagnosed with venous thromboembolism (VTE): Factors associated with treatment status.新诊断为静脉血栓栓塞症(VTE)的医疗保险患者口服抗凝剂的使用情况:与治疗状态相关的因素
PLoS One. 2025 Apr 17;20(4):e0321106. doi: 10.1371/journal.pone.0321106. eCollection 2025.
9
Disparities in Current Pulmonary Embolism Management and Outcomes: A Scientific Statement From the American Heart Association.当前肺栓塞管理与结局的差异:美国心脏协会的科学声明
Circulation. 2025 Apr 15;151(15):e944-e955. doi: 10.1161/CIR.0000000000001306. Epub 2025 Mar 20.
10
Pulmonary Embolism-Related Mortality in Patients With Cancer.癌症患者中与肺栓塞相关的死亡率
JAMA Netw Open. 2025 Feb 3;8(2):e2460315. doi: 10.1001/jamanetworkopen.2024.60315.